The Senators (Ret.) Firm, LLP How can we help you?
Haga clic aquí para visitar nuestro sitio web en Español
800.773.0849
Learn more about the different types of sexual abuse. Learn more about product liability The Senators Firm
Accolades and Associations
BlogHeaderContent
Contact Us

Dietary Supplements Discovered to Contain Dangerous Undisclosed Ingredients

Recent months have witnessed the dietary supplement industry receive an incredible amount of criticism for the increased presence of negligent practices. As a result, several lawsuits have been filed, insinuating an influx of malpractice on behalf of numerous dietary supplement manufacturers. The list of alleged transgressions consists primarily of companies who have knowingly mislead consumers with fraudulent advertisement campaigns or placed undisclosed drugs in their products. The most recent infraction has witnessed the U.S. Food and Drug Administration (FDA) advise consumers not to purchase or use “Japan Weight Loss Blue.”

While information pertaining to Japan Weight Loss Pills (Blue Version) is already difficult to find, illegitimate marketing campaigns from several vendors delude the already ambiguous situation. However, consumers are led to believe that Japan Weight Loss Blue is a second generation anti-fat ingredient, capable of eradicating fat chains and reducing belly fat. According to advertisements, green algae is the mechanism of action responsible for the significant weight loss.

Unfortunately, a recent FDA laboratory analysis confirmed that Japan Weight Loss Blue contains undisclosed ingredients with the potential to cause significant complications. According to the analysis, Japan Weight Loss Blue contains sibutramine, analogs of sibutramine, and ephedrine alkaloids. Sibutramine is a controlled substance that was removed from the U.S. market in October 2010 for safety reasons.

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact in life threatening ways with other medications a consumer may be taking.

The presence of ephedrine alkaloids was also detected in the recent FDA analysis. As a result, the FDA has warned consumers against the use Japan Weight Loss Blue dietary supplements because they may coincide with catastrophic complications. Subsequently, recent studies have confirmed that ephedrine alkaloids raise blood pressure and otherwise stress the circulatory system. Such adverse events may lead to the following complications:

  • Heart attack
  • Stroke
  • Congestive heart failure
  • Rapid, pounding, irregular heart beat
  • Other cardiac issues
  • Death

Do I Have a Japan Weight Loss Blue Lawsuit?

The trial lawyers at The Senators (Ret.) Firm, LLP have decades of experience navigating through complex legislative and regulatory issues and litigating high stakes cases all over the nation. Our law firm focuses on the representation of plaintiffs in Japan Weight Loss Blue lawsuits. We are currently accepting new cases in all 50 states.

If you or a loved one has been injured by Japan Weight Loss Blue, you may be entitled to financial compensation. For a free case review, please click the link below or call toll free 24 hrs/day 1-800-773-0849.

Your Legal Rights If you or someone close to you has become a victim of sexual abuse, please contact us to learn more about your legal rights.
800.773.0849
Attorney Web Design The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.

View Full Disclaimer

The Senators (Ret.) Firm, LLP - California Lawyer
Located at:
19100 Von Karman Ave
Suite 850

Irvine, CA 92612

View Map
Phone: (800) 773-0849
Website:
© 2018 All Rights Reserved.
Friend us on Facebook Follow us on Twitter View our Google+ Page